The best indicator for ARK Genomic (ARKG)
We backtested 382 indicators across daily, weekly and hourly charts on real ARK Genomic (ARKG) history. Here's what actually worked — risk-adjusted over the full backtest, with costs, and checked out-of-sample.
Where ARK Genomic (ARKG) stands
Computed from our own daily OHLCV history, not quoted from a third party. Moving averages use closing prices; "52-week" is the last 252 trading sessions.
Stochastic
On the daily chart, this is the strongest risk-adjusted edge we found for ARK Genomic (ARKG) over ~11.9 years — beating buy-and-hold by 9.4% CAGR.
ARK Genomic (ARKG) on the daily chart
The timeframe our backtest found best for this asset. The chart is live market data; the results above are hypothetical and historical.
Chart by TradingView. Loading it contacts tradingview.com, which may set its own cookies — see our privacy policy.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for ARK Genomic (ARKG) — beating buy-and-hold by 4.4% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Stochastic ✓ | Daily | 18.8% | 0.78 | -54.6% | 73.6% | 72 | 9.4% |
| 2 | CCI ✓ | Daily | 16.0% | 0.71 | -38.2% | 77.4% | 62 | 6.6% |
| 3 | Williams %R ✓ | Daily | 14.9% | 0.66 | -53.3% | 70.3% | 91 | 5.5% |
| 4 | Stochastic Momentum Index ✓ | Daily | 12.9% | 0.65 | -45.3% | 67.2% | 64 | 3.5% |
| 5 | SSL Channel ✓ | Daily | 15.2% | 0.65 | -49.2% | 38.2% | 136 | 5.8% |
| 6 | Stochastic RSI ✓ | Daily | 12.6% | 0.63 | -35.8% | 65.6% | 93 | 3.2% |
| 7 | Predictive Ranges ✓ | Daily | 12.7% | 0.6 | -65.4% | 41.2% | 119 | 3.3% |
| 8 | Momentum (50) ✓ | Weekly | 13.4% | 0.59 | -43.0% | 55.0% | 20 | 4.1% |
| 9 | Trade Volume Index ✓ | Daily | 12.2% | 0.56 | -51.8% | 44.1% | 118 | 2.8% |
| 10 | Vegas Tunnel ✓ | Daily | 10.3% | 0.55 | -46.7% | 23.3% | 43 | 0.9% |
| 11 | Zero-Lag LSMA ✓ | Daily | 11.7% | 0.54 | -61.8% | 45.9% | 207 | 2.3% |
| 12 | Premier Stochastic ✓ | Weekly | 12.0% | 0.54 | -52.7% | 45.0% | 20 | 2.7% |
| 13 | RSI (30) ✓ | Weekly | 11.4% | 0.54 | -51.5% | 40.0% | 15 | 2.1% |
| 14 | Connors RSI-2 ✓ | Weekly | 9.1% | 0.52 | -45.8% | 67.9% | 28 | -0.2% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
What it would take to beat buy & hold on ARK Genomic (ARKG)
47 of 541 tested setups beat buy-and-hold on ARK Genomic (ARKG) outright. Another 25 could get there with leverage they would survive — but 5 would be liquidated by their own drawdown before they caught it.
| Indicator | Beats B&H unlevered | Leverage needed | Leverage survived |
|---|---|---|---|
| Connors RSI | 2 | none needed | 2.95× |
| MA Envelope | 2 | none needed | 3.01× |
| QQE | 1 | 1.03× | 2.34× |
| Demand Index | 1 | 1.12× | 2.8× |
| Camarilla Pivots | 1 | 1.76× | 2.71× |
| Twiggs Money Flow | 1 | 2.14× | 3.19× |
Out-of-sample, costs included. A setup is only listed if the leverage it needs is less than the leverage its own worst drawdown survives — when it isn't, no amount of leverage gets there. Volatility drag isn't modelled, so these are the optimistic case. Every indicator, ranked this way
For ARK Genomic (ARKG), Stochastic on the daily timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More etf
Get alerted when ARK Genomic’s signal flips
We track ARK Genomic daily. Its backtested best indicator, Stochastic (Daily), is long right now — we'll email you the moment that changes. Free, no spam, unsubscribe any time.